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Abstract
Biogenic polyamines are essential for cell growth and differentiation, while polyamine analogues exert antitumor activity in
multiple experimental model systems, including breast and lung cancer. Dendrimers are widely used for drug delivery in
vitro and in vivo. We report the bindings of biogenic polyamines, spermine (spm), and spermidine (spmd), and their
synthetic analogues, 3,7,11,15-tetrazaheptadecane.4HCl (BE-333) and 3,7,11,15,19-pentazahenicosane.5HCl (BE-3333) to
dendrimers of different compositions, mPEG-PAMAM (G3), mPEG-PAMAM (G4) and PAMAM (G4). FTIR and UV-visible
spectroscopic methods as well as molecular modeling were used to analyze polyamine binding mode, the binding constant
and the effects of polyamine complexation on dendrimer stability and conformation. Structural analysis showed that
polyamines bound dendrimers through both hydrophobic and hydrophilic contacts with overall binding constants of
Kspm-mPEG-G3=7.6610
4 M
21, Kspm-mPEG-PAMAM-G4=4.6610
4 M
21,K spm-PAMAM-G4=6.6610
4 M
21, Kspmd-mPEG-G3=1.0610
5 M
21,
Kspmd-mPEG-PAMAM-G4=5.5610
4 M
21,K spmd-PAMAM-G4=9.2610
4 M
21, KBE-333-mPEG-G3=4.2610
4 M
21, KBe-333-mPEG-PAMAM-G4=
3.2610
4 M
21,K BE-333-PAMAM-G4=3.6 610
4 M
21, KBE-3333-mPEG-G3=2.2 610
4 M
21, KBe-3333-mPEG-PAMAM-G4=2.4 610
4 M
21,
KBE-3333-PAMAM-G4=2.3610
4 M
21. Biogenic polyamines showed stronger affinity toward dendrimers than those of synthetic
polyamines, while weaker interaction was observed as polyamine cationic charges increased. The free binding energies
calculated from docking studies were: 23.2 (spermine), 23.5 (spermidine) and 23.03 (BE-3333) kcal/mol, with the following
order of binding affinity: spermidine-PAMAM-G-4.spermine-PAMMAM-G4.BE-3333-PAMAM-G4 consistent with spectro-
scopic data. Our results suggest that dendrimers can act as carrier vehicles for delivering antitumor polyamine analogues to
target tissues.
Citation: Mandeville J-S, Bourassa P, Thomas TJ, Tajmir-Riahi H-A (2012) Biogenic and Synthetic Polyamines Bind Cationic Dendrimers. PLoS ONE 7(4): e36087.
doi:10.1371/journal.pone.0036087
Editor: Laurent Kreplak, Dalhousie University, Canada
Received February 21, 2012; Accepted March 26, 2012; Published April 27, 2012
Copyright:  2012 Mandeville et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors have no funding or support to report.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: tajmirri@uqtr.ca
Introduction
Polyamine analogues (Fig. 1) exert antitumor activity in multiple
experimental model systems, including breast and lung cancer
models and they are being used in clinical trials [1–5]. Synthetic
polyamines can mimic some of the self-regulatory functions of
biogenic polyamines but are unable to substitute for natural
polyamines in their growth promoting role [6–13]. Natural
polyamines are ubiquitous cellular cations and are involved in
cell growth and differentiation (14). They are capable of
modulating gene expression and enzyme activities, activation of
DNA synthesis, and facilitating protein-DNA interactions [13–20].
Even though interactions of biogenic and synthetic polyamines
with DNA and RNA are well characterized [21–25], little is
known about their interaction with therapeutically important
synthetic polymers, such as dendrimers [26].
Synthetic polymers with a specific shape and size play important
roles in the development of modern drug and gene delivery
systems [27–29]. Dendrimers are unique synthetic macromole-
cules of nanometer dimensions with a highly branched structure
and globular shape [29,30]. Among dendrimers, polyamidoamine
(PAMAM) dendrimers (Fig. 1) have received most attention as
potential gene and drug delivery systems [31–33]. Several attempts
have been made to design different dendrimers as drug carriers
[34]. For example, anticancer fluorouracil drug was attached to
dendrimers with a cyclic core [35], while dendrimers with
poly(ethylene glycol) grafts were used to encapsulate antitumor
drugs adriamycin and methotrexate [36]. Similarly, it has been
shown that a poly(propyleneimine) dendrimers endcapped with 64
L-phenylalanine encapsulated nearly 4 molecules of Bengal Rose
for every dendritic molecule [37]. Since dendrimers have a large
number of terminal groups to which drug molecules can be
attached, they can carry drug molecules with a high efficiency.
They contain several binding sites for hydrophobic, hydrophilic,
cationic and anionic drugs. In developing dendrimers for drug
delivery, it is important to use dendrimers with low toxicity and
excellent biocompatibility. However, dendrimers such as PAMAM
(polyamidoamine) and polypropyleneimine (PPI) are toxic. It has
been demonstrated that modification of the amino groups on the
periphery of dendrimers with poly(ethylene glycol) could reduce
toxicity and increase biocompatibility [38–40]. Poly(ethylene
glycol) is nontoxic, nonimmunogenic and water soluble, and its
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e36087Figure 1. Chemical structures of polyamines and PAMAM-G4 dendrimer.
doi:10.1371/journal.pone.0036087.g001
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that combine the properties of both the substrate and the polymer.
However, conjugate formation can alter the binding affinity of
dendrimers in general since a part of the functional pendant
groups are removed by conjugation.
In this report, we present the results of spectroscopic and
molecular docking experiments on the interaction of biogenic and
synthetic polyamines with dendrimers of different composition,
PAMAM (G4), m-PEG-PAMAM (G3) and m-PEG-PAMAM
(G4), in aqueous solution, using a constant polymer concentration
and different drugs concentrations. Structural data regarding
polyamine binding modes as well as the stability of polyamine-
dendrimer complexes are presented in this report.
Materials and Methods
Materials
Spermine.4HCl and spermidine.3HCl were purchased from
Sigma Chemical Company and used as supplied. Polyamine
analogues, BE-333 and BE-3333, were synthesized in the
laboratory of Dr. Akira Shirahata (Josai University, Saitama,
Japan). PAMAM-G4 (MW 14214 g/mol) was purchased from
Aldrich Chemical Co and used as supplied. mPEG-PAMAM-G3
(MW 13423 g/mol) and mPEG-PAMAM-G4 (MW 19214 g/mol)
were synthesized according to published methods [35,41,42].
mPEG block has a molecular weight of 5000 g/mol. Other
chemicals were of reagent grade and used without further
purification.
Preparation of stock solutions
Dendrimer solution (1 mM) were prepared in distilled water
and diluted to various concentrations in Tris-HCl buffer.
Polyamine solutions (1 mM) were prepared in water and diluted
in Tris-HCl buffer. The pH of stock solutions was kept at 760.2.
FTIR spectroscopic measurements
Infrared spectra were recorded on a FTIR spectrometer (Impact
420 model), equipped with deuterated triglycine sulphate (DTGS)
Figure 2. FTIR spectra and difference spectra (diff.) in the region of 1800-600 cm
21 of hydrated films (pH 7.4) for free mPEG-
PAMAM-G3 (A), mPEG-PAMAM-G4 (B) PAMAM-G4 (C) (0.5 mM) and their spermine complexes obtained at different spermine
concentrations (indicated on the figure).
doi:10.1371/journal.pone.0036087.g002
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solutions were added drop-wise to dendrimer solutions, with
constant stirring to ensure the formation of homogeneous solutions
and to reach target polyamine concentrations of 0.125, 0.25, and
0.5 mM and a final dendrimer concentration of 0.5 mM. Spectra
were collected after 2 h incubation of polyamine and polymer
solution at room temperature, using hydrated films [42].
Interferograms were accumulated over the spectral range of
4000-600 cm
21, with a nominal resolution of 4 cm
21 and 100
scans. The difference spectra [(dendrimer+polyamine solution)2
(dendrimer solution)] were generated, using dendrimer bands at
843 (mPEG-PAMAM-G3), 841 (mPEG-PAMAM-G4) and
1037 cm
21 (PAMAM-G4). These vibrations are related to the
polymers C-C stretching and semi ring skeletal modes [43,44] that
show no spectral changes (intensity or shifting) upon polyamine-
dendrimer complex formation, and cancelled on spectral subtrac-
tion.
UV-Visible spectroscopy
The UV-Vis spectra were recorded on a Perkin-Elmer Lambda
spectrophotometer with a slit of 2 nm and scan speed of
400 nm min
21. Quartz cuvettes of 1 cm were used. The
absorbance measurements were performed at pH 7.0 by keeping
the concentration of dendrimer constant (0.10 mM), while
increasing polyamine concentrations (0.005 mM to 0.10 mM).
The binding constants were obtained according to the method
described by Connors [45]. It is assumed that the interaction
between the ligand L and the substrate S is 1:1; for this reason a
single complex SL (1:1) is formed. It was also assumed that the sites
(and all the binding sites) are independent and all species obeyed
the Beer’s law. A wavelength is selected at which the molar
absorptivities eS (molar absorptivity of the substrate) and e11
(molar absorptivity of the complex) are different. In the absence of
ligands and light path length (b) of 1 cm and at total substrate
concentration St, the solution absorbance is given by the following
equation:
Figure 3. FTIR spectra and difference spectra (diff.) in the region of 1800-600 cm
21 of hydrated films (pH 7.4) for free mPEG-
PAMAM-G3 (A), mPEG-PAMAM-G4 (B) PAMAM-G4 (C) (0.5 mM) and their spermidine complexes obtained at different spermidine
concentrations (indicated on the figure).
doi:10.1371/journal.pone.0036087.g003
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At total concentration Lt of a ligand, the absorbance of a solution
containing the same total substrate concentration is:
AL~eSbS ½  zeLbL ½  ze11bS L ½  ð 2Þ
where [S] is the concentration of the uncomplexed substrate, [L]
the concentration of the uncomplexed ligand and [SL] is the
concentration of the complex) which, combined with the mass
balance on S and L, gives
AL~eSbStzeLbLtzDe11bS L ½  ð 3Þ
where De11=e112eS2eL (eL molar absorptivity of the ligand). By
measuring the solution absorbance against a reference containing
ligand at the same total concentration Lt, the measured
absorbance becomes
A~eSbStzDe11bS L ½  ð 4Þ
Combining equation (4) with the stability constant definition
K11=[SL]/[S][L], gives
DA~K11De11bS ½  L ½  ð 5Þ
where DA=A2Ao . From the mass balance expression
St=[S]+[SL] we get [S]=St/(1+K11[L]), which is equation (5),
giving equation (6) at the relationship between the observed
absorbance change per centimeter and the system variables and
parameters.
DA
b
~
StK11De11 L ½ 
1zK11 L ½ 
ð6Þ
Figure 4. FTIR spectra and difference spectra (diff.) in the region of 1800-600 cm
21 of hydrated films (pH 7.4) for free mPEG-
PAMAM-G3 (A), mPEG-PAMAM-G4 (B) PAMAM-G4 (C) (0.5 mM) and their BE-333 complexes obtained at different BE-333
concentrations (indicated on the figure).
doi:10.1371/journal.pone.0036087.g004
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dependence on free ligand concentration.
The double-reciprocal form of plotting the rectangular
hyperbola
1
y
~
f
d
:1
x
z
e
d
, is based on the linearization of equation
(6) according to the following equation,
b
DA
~
1
StK11De11 L ½ 
z
1
StDe11
ð7Þ
Thus the double reciprocal plot of 1/DA versus 1/[L] is linear
and the binding constant can be estimated from the following
equation
K11~
intercept
slope
ð8Þ
Molecular modeling
The PAMAM-G4 and polyamine structures were generated
using the ChemOffice Ultra 6.0 software suite. The polyamine was
then automatically docked to the rough PAMAM-G4 structure
using ArgusLab 4.0.1 (ArgusLab 4.0.1, Mark A. Thompson,
Planaria Software LLC, Seattle,WA, http://www.arguslab.com).
The docked polyamine-PAMAM-G4 structures were optimized by
means of molecular dynamics using the MM+ force field available
in HyperChem Pro 7.0. The heat time and run time for the
simulations were 2 ps and 28 ps respectively with a step size of
0.001 ps. The temperature was initially set at 1 K and gradually
increased to 300 K during the heat time by increments of 30 K. In
all the simulations, equilibrium (achieving constant temperature
near the selected final value) was reached after approximately
20 ps. The free binding energies of the optimized PAMAM-G4–
polyamine complex structures were calculated using the Ascore
scoring function provided in the ArgusLab software.
Figure 5. FTIR spectra and difference spectra (diff.) in the region of 1800-600 cm
21 of hydrated films (pH 7.4) for free mPEG-
PAMAM-G3 (A), mPEG-PAMAM-G4 (B) PAMAM-G4 (C) (0.5 mM) and their BE-3333 complexes obtained at different BE-3333
concentrations (indicated on the figure).
doi:10.1371/journal.pone.0036087.g005
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FTIR spectral analysis of polyamine-dendrimer complexes
Figure 2 shows the infrared spectra and difference spectra of
dendrimers complexed with spermine. Spectral shifting was
observed for the polymer C=O, C-N, C-O stretching and NH
bending [43,44] due to drug hydrophilic interactions with polymer
polar groups. The major infrared bands at 1631 (C=O stretch
and NH bending), 1556 (C-N stretch), 1405, 1299 (C-O), 1118,
1061 and 1039 cm
21 (C-O and C-C stretch), in the infrared
spectra of the free mPEG-PAMAM-G3 exhibited shifting and
intensity increases upon spermine binding (Figs. 2A). Similarly, the
major infrared bands of the free mPEG-PAMAM-G4 at 1650,
1558, 1469, 1359, 1285, 1114 and 1062 cm
21 showed shifting and
intensity changes upon complex formation with spermine (Fig. 2
B). The infrared bands of the free PAMAM-G4 at 1650, 1558,
1471, 1380, 1159 and 1060 cm
21 also shifted upon spermine
interaction (Fig. 2C). The observed spectral shifting was
accompanied with gradual increase in intensity of the above
vibrational frequencies in the difference spectra [(dendrimer+-
spermine solution)2(dendrimer solution)] of drug-polymer com-
plexes (Fig. 2A, 2B and 2C, diffs). The spectral changes observed
are attributed to the hydrophilic interactions of polyamine polar
groups with dendrimer NH2, C-O and C-N groups. The
hydrophilic interaction is more pronounced at high spermine
concentrations as evidenced by an increase in the intensity of
several positive bands, centered at 1650-1000 cm
21 in the
difference spectra of polyamine-dendrimer complexes (Fig. 2A,
2B and 2C, compare diffs 0.125 and 0.5 mM).
Spermidine-polymer complex formation produced major spec-
tral changes of the dendrimer infrared vibrational frequencies
(Fig. 3). The spectral changes were observed mainly for the C=O,
C-N, C-O stretching and NH bending modes [43,44] in the region
of 1650-1000 cm
21 of the infrared spectra of mPEG-PAMAM-
G3, mPEG-PAMAM-G4 and PAMAM-G4, upon complex
formation with spermidine (Fig. 3A, 3B and 3C). The spectral
shifting was associated with an increase in intensity of these
vibrations in the difference spectra of spermidine-dendrimer
complexes (Fig. 3A, 3B and 3C, diffs). More perturbations of
polymer spectra occurred at high polyamine concentrations, as the
intensity of the positive features increased as a result of spermidine-
polymer complex formation (Fig. 3A, 3B and 3C. Compare diffs of
Figure 6. FTIR spectra in the region of 3300-2800 cm
21 of hydrated films (pH 7.4) for free mPEG-PAMAM-G3 (A), mPEG-PAMAM-G4
(B) and PAMAM-G4 (C) and their polyamine complexes obtained with 0.5 mM polymer and polyamine concentrations.
doi:10.1371/journal.pone.0036087.g006
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attributed to the hydrophilic contacts of drug OH groups with
dendrimer NH2, C-O and C-N groups.
BE-333-dendrimer complexation caused minor spectral changes
(shifting and intensity) at low polyamine analogue concentration,
while major spectral changes occurred at high polyamine
concentrations (Fig. 4A, 4B and 4C, 0.125 and 0.5 mM). The
observed spectral changes (shifting and intensity increases) are due
to BE-333-polymer complex formation via dendrimer C-O, C-N
and NH2 and the polyamine NH2 groups.
The infrared spectra of BE-3333-dendrimer complexes present-
ed in Fig. 5 showed minor spectral changes at low polyamine
concentration and major shifting and intensity changes at high
BE-3333 concentrations (Fig. 5A, 5B, 5C, compare 0.125 and
0.5 mM). The observed spectral changes are due to polyamine-
polymer interaction via dendrimer C-O, C-N and NH and
polyamine NH2 groups (hydrophilic contacts).
Figure 7. UV-visible spectra of mPEG-PAMAM-G3, mPEG-PAMAM-G4 and PAMAM-G4 and their complexes with spermine and
spermidine with free dendrimer at 100 mM and complexes c-g at 5, 10, 20, 40 and 80 mM. (A, B and C) for spermine and c-g at 5, 10,
20, 40, and 80 mM for spermidine.mPEG-G3 (D), c-h c-g at 5, 10, 20, 40, 80 and 100 mM for spermidine-mPEG-G4 (E) and spermidine-
PAMAM-G4 (F). Plots of 1/(A2A0) vs (1/ polyamine concentration) and binding constant (K) for spermine (A9,B 9 and C9) and
spermidine (D9,E 9 and F9).
doi:10.1371/journal.pone.0036087.g007
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PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e36087Figure 8. UV-visible spectra of mPEG-PAMAM-G3, mPEG-PAMAM-G4 and PAMAM-G4 and their complexes with BE-333 and BE-
3333 with free dendrimer at 100 mM and complexes c-h at 5, 10, 20, 40, 80 and 100 mM. (A, B and C); c-h at 5, 10, 20, 40, 80 and
100 mM for BE-3333-mPEG-G3 (D), c-i at at 5, 10, 20, 40, 60, 80 and 100 mM BE-3333-mPEG-G4 (E) and c-f at 5, 10, 20 and 40 mM ( F).
Plots of 1/(A2A0) vs (1/ polyamine concentration) and binding constant (K) for BE-333 (A9, B9 and C9) and BE-3333 (D9, E9 and F9).
doi:10.1371/journal.pone.0036087.g008
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The effect of polyamine-polymer complex formation on
dendrimer antisymmetric and symmetric CH2 stretching vibra-
tions in the region of 3000-2800 cm
21 was investigated by infrared
spectroscopy [43.44]. From Fig. 6A, the antisymmetric and
symmetric CH2 bands of the free mPEG-PAMAM-G3 and its
polyamine complexes were assigned as follows: free mPEG-
PAMAM-G3 at 2942, 2912 and 2890 cm
21, spermine-mPEG-
PAMAM-G3 at 2944 and 2889 cm
21; spermidine-mPEG-PA-
MAM-G3 at 2943, 2917 and 2889 cm
21; BE-333-mPEG-
PAMAM-G3 at 2942, 2917 and 2889 cm
21; and BE-3333-
mPEG-PAMAM-G3 at 2944, 2918 and 2889 cm
21. In Fig. 6B,
the antisymmetric and symmetric CH2 bands of the free mPEG-
PAMAM-G4 and its polyamine complexes were observed as
follows: mPEG-PAMAM-G4, 2958, 2933 and 2817 cm
21;
spermine-mPEG-PAMAM-G4, 2944, 2984 and 2859 cm
21;
spermidine-mPEG-PAMAM-G4, 2942, 2983 and 2861 cm
21;
BE-333-mPEG-PAMAM-G4, 2947, 2983 and 2857 cm
21; BE-
3333-mPEG-PAMAM-G4, 2949, 2983 and 2859 cm
21. Similarly,
Fig. 6C shows the CH2 stretching vibrations of the free PAMAM-
G4 and its complexes as follows: PAMAM-G4, 2938, 2881 and
2838 cm
21; spermine-PAMAM-G4, 2935 and 2876 and
2838 cm
21; spermidine-PAMAM-G4, 2936, 2872 and
2837 cm
21; BE-333-PAMAM-G4, 2937, 2876 and 2839 cm
21;
and BE-3333-PAMAM-G4, 2936, 2873 and 2837 cm
21. The
observed spectral shifting for polymer CH2 vibrations is indicative
of some degree of hydrophobic interactions for polyamine-
dendrimer complexes. This is due to the hydrophobic contacts
via polyamine hydrophobic parts (aliphatic CH2 groups) and the
interior hydrophobic cavities present in dendrimers.
UV-Visible spectra and stability of polyamine-dendrimer
complexex
The UV spectra of polyamine-dendrimer complexes are
presented in Figures 7 (spermine and spermidine) and 8 (BE-333
and BE-3333). There is clear evidence that as polyamine complex
formation occurred, major intensity increases of the dendrimer
UV band, centered at 260–290 nm, also occurred [46,47]. The
spectral changes are more pronounced in the case of biogenic
spermine and spermidine than those of polyamine analogues BE-
333 and BE-3333 (Figs. 7 and 8).
The polyamine-dendrimer binding constants, obtained (accord-
ing to the method described in experimental section (using plots of
1/(A2A0) vs (1/polyamine concentrations), showed one binding
constant for each polyamine-polymer complex formation (Figs. 7
and 8 and Table 1). The calculated binding constants are:
Kspm-mPEG-G3=7.6 610
4 M
21, Kspm-mPEG-PAMAM-G4=4.6 610
4 M
21,
Kspm-PAMAM-G4=6.6 610
4 M
21, Kspmd-mPEG-G3=1.0 610
5 M
21,
Kspmd-mPEG-PAMAM-G4=5.5 610
4 M
21,K spmd-PAMAM-G4=9.2 6
10
4 M
21,KBE-333-mPEG-G3=4.2 610
4 M
21,KBe-333–mPEG-PAMAM-G4=
3.2610
4 M
21,K BE-333-PAMAM-G4=3.6 610
4 M
21,KBE-3333-mPEG-G3=
2.2610
4 M
21, KBe-3333–mPEG-PAMAM-G4=2.4 610
4 M
21,
KBE-3333-PAMAM-G4=2.3610
4 M
21 (Table 1). The binding affinity
of biogenicpolyamines toward dendrimers was stronger than that of
synthetic polyamines, while weaker interaction was observed as
polyamine cationic charge increased (Table 1). The reason why
biogenic polyamine-dendrimers are more stable than those of the
syntheticpolyaminescanbe dueto other factors suchas the primary
amines ((NH3+) in biogenic polyamines, that possess a higher
density of positive charge than the secondary ones ((NH2+), in
synthetic polyamines and also the presence of more hydrophobic
contacts in the biogenic polyamine-polymer complexes.
Docking studies
Our results from FTIR and UV-visible spectroscopic methods
were complemented with molecular dynamic simulations in which
the polyamines spermine, spermidine and BE-333 were automat-
ically docked to PAMAM-G4 and the resulting structures were
optimized using the MM+ force field to determine the preferred
conformations of the polyamine-polymer complexes. The simula-
tion results are shown in Fig. 9 and Table 2. The models showed
that polyamines are located on the surface of dendrimers and in
cavities of PAMAM-G4 polymer (Fig. 9). The free binding
energies calculated from docking studies were as follows: spermine,
(3.2; spermidine, (3.5 and BE-333, (3.03 kcal/mol, with the
following order of binding affinity: spermidine-PAMAM-G-
4.spermine-PAMMAM-G4.BE-333-PAMAM-G4. These re-
sults are consistent with the data obtained from spectroscopic
studies (Tables 1 and 2).
Discussion
Several synthetic macromolecules have been developed as drug
and gene delivery vehicles [27,28,30,32]. An ideal drug carrier
vehicle must be biochemically inert and non-toxic, while
protecting the payload (drug) from dissociation until it reaches
the target site, and capable of releasing the drug at target site.
Among synthetic polymers, dendrimers are unique macromole-
cules with nanometer dimensions, a highly branched structure and
globular shape. These macromolecules have uniform size and are
mono-disperse, with modifiable surface functionality as well as
internal cavities. They contain several binding sites for hydropho-
bic, hydrophilic, cationic and anionic drugs (Fig. 1) Dendrimers
are capable of binding and transporting DNA, RNA and drug
molecules with high efficiency [30,32]. Dendrimers can be used as
a containers to encapsulate drug molecules and carry them to
different targets in vivo [35,48,49]. It has been shown that
dendrimers with a hydrophobic interior and hydrophilic chain
ends are capable of solubilizing hydrophobic compounds in
aqueous solutions [49,50,51]. Attempts have been made to design
different dendrimers as drug carriers [36]. For example,
anticancer drug, 5-fluorouracil (5-FU) was attached to dendrimers
with cyclic core [36]. Dendrimers having poly(ethylene glycol)
Table 1. Binding constants of polyamine-dendrimers (K M
21).
Polyamines mPEG-G3 mPEG-G4 PAMAM-G4
Spermine (7.661)610
4 (4.660.6)610
4 (6.661)610
4
Spermidine (160.4)610
5 (5.560.7)610
4 (9.261)610
4
BE-333 (4.260.6)610
4 (3.260.5)610
4 (3.6.60.6)610
4
BE-3333 (2.260.5)610
4 (2.460.4)610
4 (2.360.4)610
4
doi:10.1371/journal.pone.0036087.t001
Table 2. Free binding energy of the docked polyamine-
PAMAM complexes.
Complex DGbinding (kcal/mol)
Spermidine – PAMAM-G4 23.50
Spermine – PAMAM-G4 23.20
BE-333 – PAMAM-G4 23.03
doi:10.1371/journal.pone.0036087.t002
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and methotrexate [37]. The complexation of dendrimers with
anti-inflammatrory drug flurbiprofen was studied in vitro and in
vivo, while drug biodistribution in different organs has been
monitored [39]. Gene delivery targeted to brain has been
attempted using transferring-conjugated polyethyleneglycol-mod-
ified polyamidoamine dendrimer [40]. The purpose of our
investigation was to analyze the interaction of dendrimers with
biogenic and synthetic polyamines in order to test the feasibility of
these nanocarrier molecules for polyamine-based drug delivery.
Infrared spectroscopic data in the region of 1700-1000 cm
21,
where most of the polymer in-plane vibrations related to C=O,
C-N, NH and C-O modes are located, exhibit spectral changes
(shifting and intensity variations) upon polyamine-polymer com-
plex formation. These changes are more profound at high
polyamine concentrations. There was clear evidence that the
hydrophilic polyamine entity induced more perturbations of
polymer hydrophilic group vibrational frequencies, with the
following order of spectral changes: spermidine.spermine.BE-
333.BE-3333 (Figs. 2, 3, 4, 5). This can be expected since
polyamines with several positively charged NH and NH2 groups
show more affinity for dendrimer terminal groups than those of
the hydrophobic groups located in polymer interior cavities.
Molecular modeling also showed polyamine binding with the
dendrimer with spermidine-PAMAM more stable than spermine-
and BE-333-PAMAM complexes.
In conclusion, we find that synthetic and natural polyamines are
capable of binding to different dendrimers. The binding affinity is
relatively low to enable them to act as polyamine delivery vehicles,
especially polyamine analogues under investigation as cancer
chemotherapeutic agents.
Author Contributions
Conceived and designed the experiments: JSM PB TJT HATR. Performed
the experiments: JSM PB TJT. Analyzed the data: JSM PB. Contributed
reagents/materials/analysis tools: TJ. Wrote the paper: HATR.
Figure 9. Optimized polyamine-PAMAM-G4 docking structures. The polyamines are shown in yellow color. (A) shows whole PAMAM-G4 in
spheres with spermine and (A9) shows the zoom on the binding site represented in sticks. (B) shows whole PAMAM-G4 in spheres with spermidine
and (B9) shows the binding site represented in sticks. (C) whole PAMAM-G4 in spheres with BE-333 and (C9) shows the binding site in represented in
sticks.
doi:10.1371/journal.pone.0036087.g009
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